Subcutaneous versus intravenous bortezomib in two different induction therapies for fewly diagnosed multiple myeloma: Elektronische Ressource$dsubgroup analysis from the GMMG-MM5 trial
Gespeichert in:
| Weitere Verfasser: | , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) Konferenzschrift |
| Sprache: | Englisch |
| Veröffentlicht: |
2014
|
| In: |
Blood
Year: 2014, Jahrgang: 124, Heft: 21 |
| ISSN: | 1528-0020 |
| Online-Zugang: | Verlag, kostenfrei, Volltext: https://ashpublications.org/blood/article/124/21/3475/97713/Subcutaneous-Versus-Intravenous-Bortezomib-in-Two
|
| Verfasserangaben: | Maximilian Merz, Hans Salwender, Mathias Hänel, Uta Bertsch, Christina Kunz, Thomas Hielscher, Igor W. Blau, Christof Scheid, Elias Karl Mai, Dirk Hose, Baerbel Schurich, Markus Munder, Ingo GH Schmidt-Wolf, Christian Gerecke, Hans Walter Lindemann, Matthias Zeis, Katja Weisel, Jan Duerig, Hartmut Goldschmidt |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1505143489 | ||
| 003 | DE-627 | ||
| 005 | 20241002090856.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 150707s2014 xx |||||o 00| ||eng c | ||
| 035 | |a (DE-627)1505143489 | ||
| 035 | |a (DE-576)435143484 | ||
| 035 | |a (DE-599)BSZ435143484 | ||
| 035 | |a (OCoLC)1340701131 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 245 | 0 | 0 | |a Subcutaneous versus intravenous bortezomib in two different induction therapies for fewly diagnosed multiple myeloma |b Elektronische Ressource$dsubgroup analysis from the GMMG-MM5 trial |c Maximilian Merz, Hans Salwender, Mathias Hänel, Uta Bertsch, Christina Kunz, Thomas Hielscher, Igor W. Blau, Christof Scheid, Elias Karl Mai, Dirk Hose, Baerbel Schurich, Markus Munder, Ingo GH Schmidt-Wolf, Christian Gerecke, Hans Walter Lindemann, Matthias Zeis, Katja Weisel, Jan Duerig, Hartmut Goldschmidt |
| 264 | 1 | |c 2014 | |
| 300 | |a 1 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 07.07.2015 | ||
| 700 | 1 | |a Merz, Maximilian |d 1985- |0 (DE-588)1023626950 |0 (DE-627)718419278 |0 (DE-576)367168251 |4 oth | |
| 700 | 1 | |a Bertsch, Uta |0 (DE-588)1026849861 |0 (DE-627)727494163 |0 (DE-576)372176224 |4 oth | |
| 700 | 1 | |a Mai, Elias K. |d 1985- |0 (DE-588)1049182545 |0 (DE-627)781300274 |0 (DE-576)403130999 |4 oth | |
| 700 | 1 | |a Hose, Dirk |d 1969- |0 (DE-588)139824995 |0 (DE-627)613790308 |0 (DE-576)313431698 |4 oth | |
| 700 | 1 | |a Schurich, Bärbel |0 (DE-588)1070073237 |0 (DE-627)823264750 |0 (DE-576)429746121 |4 oth | |
| 700 | 1 | |a Goldschmidt, Hartmut |d 1956- |0 (DE-588)102258023X |0 (DE-627)717003809 |0 (DE-576)365637386 |4 oth | |
| 773 | 0 | 8 | |i In |t Blood |d Washington, DC : American Society of Hematology, 1946 |g 124(2014), 21, Artikel-ID 71052 |h Online-Ressource |w (DE-627)266886647 |w (DE-600)1468538-3 |w (DE-576)075961938 |x 1528-0020 |7 nnas |a Subcutaneous versus intravenous bortezomib in two different induction therapies for fewly diagnosed multiple myeloma Elektronische Ressource$dsubgroup analysis from the GMMG-MM5 trial |
| 773 | 1 | 8 | |g volume:124 |g year:2014 |g number:21 |g elocationid:71052 |g extent:1 |a Subcutaneous versus intravenous bortezomib in two different induction therapies for fewly diagnosed multiple myeloma Elektronische Ressource$dsubgroup analysis from the GMMG-MM5 trial |
| 856 | 4 | 0 | |u https://ashpublications.org/blood/article/124/21/3475/97713/Subcutaneous-Versus-Intravenous-Bortezomib-in-Two |x Verlag |z kostenfrei |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20150707 | ||
| 993 | |a ConferencePaper | ||
| 994 | |a 2014 | ||
| 998 | |g 102258023X |a Goldschmidt, Hartmut |m 102258023X:Goldschmidt, Hartmut |d 910000 |d 910100 |d 50000 |e 910000PG102258023X |e 910100PG102258023X |e 50000PG102258023X |k 0/910000/ |k 1/910000/910100/ |k 0/50000/ |p 19 |y j | ||
| 998 | |g 1070073237 |a Schurich, Bärbel |m 1070073237:Schurich, Bärbel |d 910000 |d 913000 |e 910000PS1070073237 |e 913000PS1070073237 |k 0/910000/ |k 1/910000/913000/ |p 11 | ||
| 998 | |g 139824995 |a Hose, Dirk |m 139824995:Hose, Dirk |d 910000 |d 910100 |d 50000 |e 910000PH139824995 |e 910100PH139824995 |e 50000PH139824995 |k 0/910000/ |k 1/910000/910100/ |k 0/50000/ |p 10 | ||
| 998 | |g 1049182545 |a Mai, Elias K. |m 1049182545:Mai, Elias K. |d 910000 |d 910100 |e 910000PM1049182545 |e 910100PM1049182545 |k 0/910000/ |k 1/910000/910100/ |p 9 | ||
| 998 | |g 1026849861 |a Bertsch, Uta |m 1026849861:Bertsch, Uta |d 910000 |d 910100 |e 910000PB1026849861 |e 910100PB1026849861 |k 0/910000/ |k 1/910000/910100/ |p 4 | ||
| 998 | |g 1023626950 |a Merz, Maximilian |m 1023626950:Merz, Maximilian |d 910000 |d 910100 |e 910000PM1023626950 |e 910100PM1023626950 |k 0/910000/ |k 1/910000/910100/ |p 1 |x j | ||
| 999 | |a KXP-PPN1505143489 |e 284828269X | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"name":{"displayForm":["Maximilian Merz, Hans Salwender, Mathias Hänel, Uta Bertsch, Christina Kunz, Thomas Hielscher, Igor W. Blau, Christof Scheid, Elias Karl Mai, Dirk Hose, Baerbel Schurich, Markus Munder, Ingo GH Schmidt-Wolf, Christian Gerecke, Hans Walter Lindemann, Matthias Zeis, Katja Weisel, Jan Duerig, Hartmut Goldschmidt"]},"id":{"eki":["1505143489"]},"origin":[{"dateIssuedKey":"2014","dateIssuedDisp":"2014"}],"relHost":[{"origin":[{"publisherPlace":"Washington, DC ; Philadelphia, Pa. ; Stanford, Calif.","dateIssuedDisp":"1946-","dateIssuedKey":"1946","publisher":"American Society of Hematology ; Saunders ; HighWire Press"}],"id":{"zdb":["1468538-3"],"eki":["266886647"],"issn":["1528-0020"]},"physDesc":[{"extent":"Online-Ressource"}],"title":[{"title_sort":"Blood","title":"Blood","subtitle":"journal of the American Society of Hematology"}],"disp":"Subcutaneous versus intravenous bortezomib in two different induction therapies for fewly diagnosed multiple myeloma Elektronische Ressource$dsubgroup analysis from the GMMG-MM5 trialBlood","note":["Gesehen am 21.04.2023"],"type":{"media":"Online-Ressource","bibl":"periodical"},"recId":"266886647","corporate":[{"role":"isb","display":"American Society of Hematology","roleDisplay":"Herausgebendes Organ"}],"language":["eng"],"pubHistory":["1.1946 -"],"titleAlt":[{"title":"Blood online"}],"part":{"issue":"21","year":"2014","extent":"1","text":"124(2014), 21, Artikel-ID 71052","volume":"124"}}],"physDesc":[{"extent":"1 S."}],"person":[{"role":"oth","display":"Merz, Maximilian","given":"Maximilian","family":"Merz"},{"given":"Uta","family":"Bertsch","role":"oth","display":"Bertsch, Uta"},{"given":"Elias K.","family":"Mai","role":"oth","display":"Mai, Elias K."},{"given":"Dirk","family":"Hose","role":"oth","display":"Hose, Dirk"},{"family":"Schurich","given":"Bärbel","display":"Schurich, Bärbel","role":"oth"},{"role":"oth","display":"Goldschmidt, Hartmut","given":"Hartmut","family":"Goldschmidt"}],"title":[{"title":"Subcutaneous versus intravenous bortezomib in two different induction therapies for fewly diagnosed multiple myeloma","subtitle":"Elektronische Ressource$dsubgroup analysis from the GMMG-MM5 trial","title_sort":"Subcutaneous versus intravenous bortezomib in two different induction therapies for fewly diagnosed multiple myeloma"}],"recId":"1505143489","language":["eng"],"note":["Gesehen am 07.07.2015"],"type":{"bibl":"article-journal","media":"Online-Ressource"}} | ||
| SRT | |a SUBCUTANEO2014 | ||